A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response

BACKGROUND AND AIM: The pathogenic process underlying the development of hepatocellular carcinoma (HCC) is not yet clear in patients with hepatitis C virus (HCV) who have received direct‐acting antiviral (DAA) therapy and achieved sustained virological response (SVR). This study validated a composit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Toshifumi, Kurosaki, Masayuki, Tamaki, Nobuharu, Yasui, Yutaka, Mori, Nami, Tsuji, Keiji, Hasebe, Chitomi, Joko, Koji, Akahane, Takehiro, Furuta, Koichiro, Kobashi, Haruhiko, Kimura, Hiroyuki, Yagisawa, Hitoshi, Marusawa, Hiroyuki, Kondo, Masahiko, Kojima, Yuji, Yoshida, Hideo, Uchida, Yasushi, Nakamura, Shinichiro, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762616/
https://www.ncbi.nlm.nih.gov/pubmed/35071784
http://dx.doi.org/10.1002/jgh3.12690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762616/
https://www.ncbi.nlm.nih.gov/pubmed/35071784
http://dx.doi.org/10.1002/jgh3.12690

Ejemplares similares